Loading clinical trials...
Loading clinical trials...
Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease: the FAST Study
The goal of this observational study is to determine the factors associated with a delayed diagnosis and/or an immediately complicated disease for CD patients. A questionnaire will be completed by the patients, each questionnaire has a patient section and a physician section.
Number of patients expected : at least 600, coming from all types of practices (ANGH (expert hospitals), GETAID (expert university hospitals) and CREGG (expert private practice)). Recruitment period : 1 year Primary endpoint : The primary endpoint is the description of the factors linked to: * The IBD * The patient (see patient questionnaire in annex 1) * The health care system * The patient's self-care Secondary endpoint : * Validation of the "red flags" in a prospective cohort. * Comparison with the EPIMAD population, especially the location and severity.
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
Start Date
February 15, 2024
Primary Completion Date
February 15, 2025
Completion Date
June 15, 2025
Last Updated
February 9, 2024
600
ESTIMATED participants
Questionnaire completion
OTHER
Lead Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
NCT07245394
NCT07089420
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions